Merck & Co Inc - Company Profile
Powered by
All the data and insights you need on Merck & Co Inc in one report.
- Save hours of research time and resources with
our up-to-date Merck & Co Inc Strategy Report
- Understand Merck & Co Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreMerck & Catalyst Calendar
Proactively evaluate Merck & Co Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Merck & Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
23 Aug 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
23 Aug 2019 | Constraining Patent Expiry (US) | Merck & Co Inc | MRK | follitropin beta | Male Health; Women's Health | Anovulation; Ovarian Hyperstimulation Syndrome; Ovulatory Dysfunction; Polycystic Ovarian Syndrome; Secondary (Hypogonadotropic) Hypogonadism; Women Infertility | GD Estimates |
15 Aug 2019 | Drug Expiry (Japan) | Merck & Co Inc | MRK | aprepitant | Central Nervous System; Gastrointestinal; Toxicology | Chemotherapy Induced Nausea and Vomiting; Major Depressive Disorder; Post Operative Nausea And Vomiting | GD Estimates |
15 Aug 2019 | Phase III Trial Initiation | Merck & Co Inc | MRK | pembrolizumab | Oncology | Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer; Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer; Prostate Cancer | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer